Employer Coverage

Share this post

User's avatar
Employer Coverage
Study shows Wegovy (semaglitude) associated with lower symptoms of heart failure in those who do not have diabetes

Study shows Wegovy (semaglitude) associated…

Sep 5, 2023

Share this post

User's avatar
Employer Coverage
Study shows Wegovy (semaglitude) associated with lower symptoms of heart failure in those who do not have diabetes
1

September 4, 2023

Read →
Comments
User's avatar
© 2025 Jeff Levin-Scherz, MD MBA FACP
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share